{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:43:00Z","timestamp":1788525780737,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biologicals.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T23:49:48Z","timestamp":1646610588000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Glycoconjugate content quantification to assess vaccine potency: A simplified approach"],"prefix":"10.1016","volume":"76","author":[{"given":"Francesca","family":"Rech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-7780","authenticated-orcid":false,"given":"Riccardo","family":"De Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-7830","authenticated-orcid":false,"given":"Luca","family":"Nompari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2062-238X","authenticated-orcid":false,"given":"Marilena","family":"Paludi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Parlati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Cianetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-5644","authenticated-orcid":false,"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2022.02.004_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/14712598.2015.993375","article-title":"Glycoconjugate vaccines: an update","volume":"15","author":"Vella","year":"2015","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.biologicals.2022.02.004_bib2","series-title":"Meningococcal vaccines","first-page":"959","author":"Granoff","year":"2004"},{"key":"10.1016\/j.biologicals.2022.02.004_bib3","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/j.vaccine.2009.06.013","article-title":"Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.02.004_bib4","series-title":"WHO technical report series, No. 897. Annex 1 Recommendations for the production and control of Haemophilus influenzae type b conjugate vaccines","year":"2000"},{"key":"10.1016\/j.biologicals.2022.02.004_bib5","series-title":"WHO technical report series, No. 924. Annex 2 Recommendations for the production and control of meningococcal group","year":"2004"},{"key":"10.1016\/j.biologicals.2022.02.004_bib6","series-title":"WHO technical report series, No. 927. Annex 2 Recommendations for the production and control of pneumococcal conjugate vaccines","year":"2005"},{"key":"10.1016\/j.biologicals.2022.02.004_bib7","series-title":"Carbohydrate-based vaccines: from concept to clinic","first-page":"279","article-title":"Chemistry, manufacturing, control, and licensure for carbohydrate-based vaccines","author":"Jones","year":"2018"},{"key":"10.1016\/j.biologicals.2022.02.004_bib8","unstructured":"US Pharmacopeia Chapter <1234> Vaccines for Human Use - Polysaccharide and Glycoconjugate Vaccines - General considerations."},{"key":"10.1016\/j.biologicals.2022.02.004_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1080\/21645515.2015.1029686","article-title":"Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents","volume":"11","author":"Saez-Llorens","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2022.02.004_bib10","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","article-title":"Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases","volume":"26","author":"Bardotti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.02.004_bib11","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(00)00427-8","article-title":"Development of a new method for the quantitative analysis of the extra cellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection","volume":"19","author":"Ricci","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.02.004_bib12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI108235","article-title":"Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants","volume":"56","author":"Gold","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biologicals.2022.02.004_bib13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2022.02.004_bib14","first-page":"83","article-title":"Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A\/C polysaccharide vaccination in Saudi Arabia","volume":"11","author":"Jokhdar","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.biologicals.2022.02.004_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination","volume":"178","author":"Granoff","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2022.02.004_bib16","author":"Granoff","year":"2013"},{"key":"10.1016\/j.biologicals.2022.02.004_bib17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0264-410X(00)00317-0","article-title":"Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults","volume":"19","author":"Borrow","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.02.004_bib18","series-title":"Influence of prior vaccination with fractional doses of a tetravalent meningococcal polysaccharide vaccine on serum bactericidal antibody responses after revaccination","author":"N\u00e6ss","year":"2009"},{"key":"10.1016\/j.biologicals.2022.02.004_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/erv.11.8","article-title":"Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines","volume":"10","author":"Poolman","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2022.02.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aat4615","article-title":"Glycoconjugate vaccines: principles and mechanisms","volume":"10","author":"Rappuoli","year":"2018","journal-title":"Sci Transl Med"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105622000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105622000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:48Z","timestamp":1760922888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105622000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":20,"alternative-id":["S1045105622000185"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2022.02.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoconjugate content quantification to assess vaccine potency: A simplified approach","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}